POS1330 ROMOSOZUMAB: ANALYSIS OF SAFETY AND DIFFERENTIAL EFFECTIVENESS IN SPECIFIC SUBGROUPS: PATIENTS WITH RHEUMATOID ARTHRITIS, DIABETES MELLITUS (DM), CORTICOSTEROIDS-INDUCED OSTEOPOROSIS | Publicación